TITLE

Acquired Myasthenia Gravis Associated with Oral Sarcoma in a Dog

AUTHOR(S)
Stepaniuk, Kevin; Legendre, Loïc; Watson, Shelby
PUB. DATE
December 2011
SOURCE
Journal of Veterinary Dentistry;Winter2011, Vol. 28 Issue 4, p242
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Acquired myasthenia gravis is a common neuromuscular disorder resulting from autoantibody directed against the postsynaptic acetylcholine nicotinic receptors in skeletal muscle. Myasthenia gravis has been reported previously as a paraneoplastic syndrome. This case report presents myasthenia gravis secondary to an oral sarcoma in a juvenile Mastiff dog.
ACCESSION #
79812440

 

Related Articles

  • Anaesthetic Management of Myasthenia Gravis with Thymic Mass in Facial Trauma. Sharma, deepak; Singh, Dheer // Indian Anaesthetists' Forum;2010, Special section p1 

    Myasthenia gravis is an immunologic disorder characterised by polyclonal antibodies directed against nicotinic acetylcholine receptors at postneuromuscular junction. This case describes perioperative management of a patient suffering facial trauma with underlying myasthenia gravis with thymic...

  • Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. Caliandro, Pietro; Luigetti, Marco; Ricci, Enzo; Mirabella, Massimiliano; Tonali, Pietro Attilio; Padua, Luca // Neurological Sciences;Feb2010, Vol. 31 Issue 1, p79 

    Myasthenia gravis (MG) and paraneoplastic cerebellar degeneration (PCD) are immune-mediated syndromes that can represent paraneoplastic disorders. We report a patient with history of ovarian carcinoma that presented with ptosis, diplopia and gait ataxia. Neurophysiological examination and...

  • Miastenia gravis: caso clínico y revisión de la bibliografía. García Zenón, Tania; Villalobos Silva, José Antonio; Rodríguez Hinojosa, Herminio // Medicina Interna de Mexico;may/jun2011, Vol. 27 Issue 3, p299 

    Myasthenia Gravis (miastenia gravis) is an antibody disorder of the neuromuscular junction involving the production of auto antibodies directed against the skeletal muscle receptors, most of them of acetylcholine (acetilcolinaR). It's a relatively uncommon disease, although prevalence has...

  • Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. Romi, Fredrik; Suzuki, Shigeaki; Suzuki, Norihiro; Petzold, Axel; Plant, Gordon; Gilhus, Nils // Journal of Neurology;Jul2012, Vol. 259 Issue 7, p1312 

    Myasthenia gravis (MG) is an autoimmune disease characterized by skeletal muscle weakness mainly caused by acetylcholine receptor antibodies. MG can be divided into generalized and ocular, and into early-onset (<50 years of age) and late-onset (≥50 years of age). Anti-Kv1.4 antibodies...

  • Timeline: Unravelling the pathogenesis of myasthenia gravis. Vincent, Angela // Nature Reviews Immunology;Oct2002, Vol. 2 Issue 10, p797 

    Myasthenia gravis is a relatively rare neurological disease that is associated with loss of the acetylcholine receptors that initiate muscle contraction. This results in muscle weakness, which can be life-threatening. The story of how both the physiological basis of the disease and the role of...

  • The Molecular Anatomy of Human Hsp60 and its Similarity with that of Bacterial Orthologs and Acetylcholine Receptor Reveal a Potential Pathogenetic Role of Anti-Chaperonin Immunity in Myasthenia Gravis. Marino Gammazza, Antonella; Bucchieri, Fabio; Grimaldi, Luigi; Benigno, Arcangelo; Conway de Macario, Everly; Macario, Alberto; Zummo, Giovanni; Cappello, Francesco // Cellular & Molecular Neurobiology;Aug2012, Vol. 32 Issue 6, p943 

    Heat-shock protein 60 (Hsp60) is ubiquitous and highly conserved being present in eukaryotes and prokaryotes, including pathogens. This chaperonin, although typically a mitochondrial protein, can also be found in other intracellular sites, extracellularly, and in circulation. Thus, it can signal...

  • Myasthenia gravis -- a case of lost potential. CAMPEANU, RON // Chemistry in Australia;Jul2009, Vol. 76 Issue 6, p19 

    The article offers information on myasthenia gravis, an autoimmune disease caused by a dysfunction of the nervous system, specifically acetylcholine receptors. It states that the common cause of this disease is an acquired immunological abnormality, however, some cases result from genetic...

  • Extracorporeal Immunoglobulin Elimination for the Treatment of Severe Myasthenia Gravis. Blaha, M.; Pitha, J.; Blaha, V.; Lanska, M.; Maly, J.; Filip, S.; Langrova, H. // Journal of Biomedicine & Biotechnology;2010, p1 

    Myasthenia gravis (MG) is a neuromuscular disorder leading to fluctuating muscle weakness and fatigue. Rarely, long-term stabilization is not possible through the use of thymectomy or any known drug therapy. We present our experience with extracorporeal immunoglobulin (Ig) elimination by...

  • Clinical and serological study of myasthenia gravis in HuBei Province, China. Xiaofan Zhang; Mingshan Yang; Jinzhi Xu; Min Zhang; Lang, Bethan; Wei Wang; Vincent, Angela // Journal of Neurology, Neurosurgery & Psychiatry;Apr2007, Vol. 78 Issue 4, p386 

    Background: Ocular and childhood myasthenia gravis (MG) cases seem relatively more common in Oriental than in Caucasian populations, but there have been no comprehensive serological studies on patients from mainland China. Methods: 391 unselected patients with MG attending Tongji Hospital in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics